Seed Round

With its lead drug for a rare pediatric liver disease entering late-stage trials, NorthSea Therapeutics adds a veteran drug developer to its board.

New research shows parents welcome corporate sponsors in schools to fill funding gaps, creating a powerful new marketing channel built on community trust.

A Georgia firm's painless patch technology earns top honors, promising to revolutionize medicine delivery and solve critical global health challenges.

A new protocol aims to tokenize AI hardware, bridging a $2.5T finance gap and creating a new asset class for the digital age. Here's how it works.

Fueled by a $250K grant from Allen Family Philanthropies, a new pilot aims to tackle Seattle's infamous social isolation with a structured national plan.

After a standout debut at CES 2026, the emotionally intelligent robot OlloNi is heading to Kickstarter. Can it turn industry buzz into a new reality?

A landmark partnership brings multi-gigabit internet to nine underserved Georgia counties, reshaping rural life and building a blueprint for national connectivity.

Growth equity firm SEMCAP launches a new fund with Unilever Prestige visionary Vasiliki Petrou, targeting the booming wellness and longevity market.

In its first-ever Match Day, the Kansas College of Osteopathic Medicine surpassed national averages, placing new doctors in critical primary care roles.

A new venture brings AI agent battles and real-time prediction markets to your social feed, creating a novel form of entertainment and a complex new frontier.

A breakthrough in mycelium-based infection detection has prompted Mushrooms Inc. to halt a merger, betting its future on its own innovative biotech platform.

The scientist behind PARP inhibitors is backing a new approach. Dr. Alan Ashworth's appointment at Leapfrog Bio signals a major push in precision oncology.

This Michigan startup made Fast Company's Most Innovative list by using AI to turn landfill-bound wood into renewable energy and big savings for contractors.

DMZ's summit channels $210,000 to women-led startups, signaling a strategic push into Canada’s critical AI, defence, and cybersecurity sectors.

With a history of billion-dollar deals, Mark Altmeyer takes the helm at ReproNovo, aiming to commercialize its promising fertility and women's health pipeline.

Healthcare advisory giant Chartis is acquiring AI startup Leap AI, signaling a major industry shift toward building bespoke AI solutions for healthcare.

A new university-industry partnership aims to solve the key challenges of orbital computing, validating early bets on the future of decentralized AI.

Coatue and NFX alums are betting on a new data-driven model to build billion-dollar companies by pairing elite founders before an idea even exists.

A new collaboration aims to predict immunotherapy success by mapping protein interactions, offering hope for personalized non-small cell lung cancer treatment.

Princess Padmaja Kumari Parmar receives the Mary Tyler Moore Award for her advocacy, bridging a legacy of hope with a modern fight for global T1D equity.